Alpha-smooth muscle actin expression enhances cell traction force

Cell Motil Cytoskeleton. 2007 Apr;64(4):248-57. doi: 10.1002/cm.20178.

Abstract

Using an established corneal stromal cell differentiation model, we manipulated alpha-smooth muscle actin (alpha-SMA) protein expression levels in fibroblasts by treating them with TGF-beta1, bFGF, TGF-beta type I receptor inhibitor (SB-431542), and siRNA against alpha-SMA. The corresponding cell traction forces (CTFs) were determined by cell traction force microscopy. With all these treatments, we found that alpha-SMA is not required for CTF induction, but its expression upregulates CTF. This upregulation involves the modification of stress fibers but does not appear to relate to non-muscle myosin II expression or beta-actin expression. Moreover, there exists a linear relationship between alpha-SMA protein expression level and CTF magnitude. Finally, CTFs were found to vary among a population of myofibroblasts, suggesting that alpha-SMA protein expression levels of individual cells also vary.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / biosynthesis*
  • Actins / genetics
  • Actins / metabolism
  • Actins / physiology
  • Animals
  • Benzamides / pharmacology
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Corneal Stroma / cytology*
  • Corneal Stroma / drug effects
  • Corneal Stroma / metabolism*
  • Dioxoles / pharmacology
  • Fibroblast Growth Factor 2 / pharmacology
  • Mechanotransduction, Cellular
  • Muscle, Smooth / metabolism*
  • Muscle, Smooth / physiology
  • Myosin Type II / biosynthesis
  • Myosin Type II / metabolism
  • RNA, Small Interfering / genetics
  • Rabbits
  • Stress, Mechanical
  • Stromal Cells / cytology
  • Stromal Cells / drug effects
  • Stromal Cells / metabolism
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Actins
  • Benzamides
  • Dioxoles
  • RNA, Small Interfering
  • Transforming Growth Factor beta1
  • Fibroblast Growth Factor 2
  • Myosin Type II